BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 28449009)

  • 1. The prognostic value of dynamic contrast-enhanced MRI contrast agent transfer constant K
    Dickie BR; Rose CJ; Kershaw LE; Withey SB; Carrington BM; Davidson SE; Hutchison G; West CML
    Br J Cancer; 2017 May; 116(11):1436-1443. PubMed ID: 28449009
    [TBL] [Abstract][Full Text] [Related]  

  • 2. DCE-MRI of locally-advanced carcinoma of the uterine cervix: Tofts analysis versus non-model-based analyses.
    Lund KV; Simonsen TG; Kristensen GB; Rofstad EK
    Radiat Oncol; 2020 Apr; 15(1):79. PubMed ID: 32293487
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Flow versus permeability weighting in estimating the forward volumetric transfer constant (K
    Li CH; Chen FH; Schellingerhout D; Lin YS; Hong JH; Liu HL
    Magn Reson Imaging; 2017 Feb; 36():105-111. PubMed ID: 27989901
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Assessment of vessel permeability by combining dynamic contrast-enhanced and arterial spin labeling MRI.
    Liu HL; Chang TT; Yan FX; Li CH; Lin YS; Wong AM
    NMR Biomed; 2015 Jun; 28(6):642-9. PubMed ID: 25880892
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacokinetic parameters derived from dynamic contrast enhanced MRI of cervical cancers predict chemoradiotherapy outcome.
    Andersen EK; Hole KH; Lund KV; Sundfør K; Kristensen GB; Lyng H; Malinen E
    Radiother Oncol; 2013 Apr; 107(1):117-22. PubMed ID: 23333024
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prediction of early response to concurrent chemoradiotherapy in cervical cancer: Value of multi-parameter MRI combined with clinical prognostic factors.
    Zheng X; Guo W; Dong J; Qian L
    Magn Reson Imaging; 2020 Oct; 72():159-166. PubMed ID: 32621877
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Voxelwise comparison of perfusion parameters estimated using dynamic contrast enhanced (DCE) computed tomography and DCE-magnetic resonance imaging in locally advanced cervical cancer.
    Kallehauge J; Nielsen T; Haack S; Peters DA; Mohamed S; Fokdal L; Lindegaard JC; Hansen DC; Rasmussen F; Tanderup K; Pedersen EM
    Acta Oncol; 2013 Oct; 52(7):1360-8. PubMed ID: 24003852
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dynamic contrast-enhanced and dynamic susceptibility contrast perfusion MR imaging for glioma grading: Preliminary comparison of vessel compartment and permeability parameters using hotspot and histogram analysis.
    Santarosa C; Castellano A; Conte GM; Cadioli M; Iadanza A; Terreni MR; Franzin A; Bello L; Caulo M; Falini A; Anzalone N
    Eur J Radiol; 2016 Jun; 85(6):1147-56. PubMed ID: 27161065
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dynamic contrast-enhanced magnetic resonance imaging as a predictor of outcome in head-and-neck squamous cell carcinoma patients with nodal metastases.
    Shukla-Dave A; Lee NY; Jansen JF; Thaler HT; Stambuk HE; Fury MG; Patel SG; Moreira AL; Sherman E; Karimi S; Wang Y; Kraus D; Shah JP; Pfister DG; Koutcher JA
    Int J Radiat Oncol Biol Phys; 2012 Apr; 82(5):1837-44. PubMed ID: 21601373
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Peritumoral interstitial fluid flow velocity predicts survival in cervical carcinoma.
    Hompland T; Lund KV; Ellingsen C; Kristensen GB; Rofstad EK
    Radiother Oncol; 2014 Oct; 113(1):132-8. PubMed ID: 25443501
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Use of Metabolic Parameters as Prognostic Factors During Concomitant Chemoradiotherapy for Locally Advanced Cervical Cancer.
    Krhili S; Muratet JP; Roche S; Pointreau Y; Yossi S; Septans AL; Denis F
    Am J Clin Oncol; 2017 Jun; 40(3):250-255. PubMed ID: 27028351
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dynamic contrast-enhanced MRI histogram parameters predict progression-free survival in patients with advanced esophageal squamous carcinoma receiving concurrent chemoradiotherapy.
    Xu L; Ge X; Sun N; Liu X
    Acta Radiol; 2020 Oct; 61(10):1316-1325. PubMed ID: 32053003
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognostic role of diffusion weighted and dynamic contrast-enhanced MRI in loco-regionally advanced head and neck cancer treated with concomitant chemoradiotherapy.
    Garbajs M; Strojan P; Surlan-Popovic K
    Radiol Oncol; 2019 Mar; 53(1):39-48. PubMed ID: 30840595
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Diffusion-Weighted Magnetic Resonance Imaging as a Predictor of Outcome in Cervical Cancer After Chemoradiation.
    Ho JC; Allen PK; Bhosale PR; Rauch GM; Fuller CD; Mohamed AS; Frumovitz M; Jhingran A; Klopp AH
    Int J Radiat Oncol Biol Phys; 2017 Mar; 97(3):546-553. PubMed ID: 28011045
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dual-input two-compartment pharmacokinetic model of dynamic contrast-enhanced magnetic resonance imaging in hepatocellular carcinoma.
    Yang JF; Zhao ZH; Zhang Y; Zhao L; Yang LM; Zhang MM; Wang BY; Wang T; Lu BC
    World J Gastroenterol; 2016 Apr; 22(13):3652-62. PubMed ID: 27053857
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dynamic contrast-enhanced MRI of cervical cancers: temporal percentile screening of contrast enhancement identifies parameters for prediction of chemoradioresistance.
    Andersen EK; Hole KH; Lund KV; Sundfør K; Kristensen GB; Lyng H; Malinen E
    Int J Radiat Oncol Biol Phys; 2012 Mar; 82(3):e485-92. PubMed ID: 22014954
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dynamic contrast-enhanced 3-T MR imaging in cervical cancer before and after concurrent chemoradiotherapy.
    Kim JH; Kim CK; Park BK; Park SY; Huh SJ; Kim B
    Eur Radiol; 2012 Nov; 22(11):2533-9. PubMed ID: 22653283
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Combined dynamic contrast-enhanced magnetic resonance imaging and diffusion-weighted imaging to predict neoadjuvant chemotherapy effect in FIGO stage IB2-IIA2 cervical cancers.
    Zhang A; Song J; Ma Z; Chen T
    Radiol Med; 2020 Dec; 125(12):1233-1242. PubMed ID: 32424659
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Histogram analysis of DCE-MRI for chemoradiotherapy response evaluation in locally advanced esophageal squamous cell carcinoma.
    Sun NN; Ge XL; Liu XS; Xu LL
    Radiol Med; 2020 Feb; 125(2):165-176. PubMed ID: 31605354
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A comparison of tracer kinetic models for T1-weighted dynamic contrast-enhanced MRI: application in carcinoma of the cervix.
    Donaldson SB; West CM; Davidson SE; Carrington BM; Hutchison G; Jones AP; Sourbron SP; Buckley DL
    Magn Reson Med; 2010 Mar; 63(3):691-700. PubMed ID: 20187179
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.